X. Kong

Psoralidin, a prenylated coumestan, as a novel anti‐osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts

Li Chen, Yanping Wang, Yingying Li, 2017, European journal of pharmacology.

Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial

Jie Shen, Zhenlin Zhang, Zhenming Hu, 2022, Journal of orthopaedic translation.

The higher osteoprotective activity of psoralidin in vivo than coumestrol is attributed by its presence of an isopentenyl group and through activated PI3K/Akt axis.

C. Xian, Yingying Li, Yuankun Zhai, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.